Mr Carl Gibson, chief executive officer of CMA, has responded to a controversial query raised in the Review of Pharmacy Remuneration and Regulation Discussion Paper, regarding the availability of complementary medicines on pharmacy shelves versus pharmacies being forced to focus on providing conventional medical treatments.
Read the media release here